Phage therapy: Assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice

Gastroenterology and Hepatology from Bed to Bench

Volumn 10, Issue 2, 2017, Pages 131-136

  Nikkhahi, Farhad ^a   Dallal, Mohammad Mehdi Soltan ^a   Alimohammadi, Mahmood ^b   Foroushani, Abbas Rahimi ^b   Rajabi, Zahra ^a   Fardsanei, Fatemeh ^a   Imeni, Seyed Mostafa ^a,c   Bonab, Parisa Torabi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

Author keywords

Bacteriophage; Isolation; Salmonella enteritidis

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; LYTIC BACTERIOPHAGE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL THERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ELECTRON MICROSCOPY; INFECTION CONTROL; INFECTION PREVENTION; IRAN; MOUSE; NONHUMAN; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SALMONELLOSIS; SINGLE DRUG DOSE;

EID: 85019968330     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Capparelli R, Nocerino N, Iannaccone M, Ercolini D, Parlato M, Chiara M, et al. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis 2010; 201: 52-61.
2. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother 2011; 55: 1148-54.
3. Ercis S, Erdem B, Hasçelik G, Gür D. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey. Jpn J Infect Dis 2006; 59: 117-9.
4. Segovia C, Vasquez I, Maracaja-Coutinho V, Robeson J, Santander J. Complete Genome Sequence of Salmonella enterica Serovar Enteritidis Bacteriophage f18SE, Isolated in Chile. Genome Announc 2015; 3.
5. Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, et al. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by acloneO25b:H4-ST131Escherichia coli strain producing CTXM -15. Antimicrob Agents Chemother 2012; 56: 356875.
6. Biswas B, AdhyaS, Washart P, Paul B, TrostelAN, Powell B, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin resistant Enterococcus faecium. Infection and Immunity 2002; 70: 204-10.
7. Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, et al. A method for generation phage cocktail with great therapeutic potential. PLoSONE 2010 ;7: e31698.
8. Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, et al. Phagetherapy in clinical practice :treatment of human infections. Curr Pharm Biotechnol 2010; 11: 69-86.
9. Brüssow H. What is needed for phage therapy to become a reality in Western medicine? Virology 2012; 434: 138-42.
10. Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol 2013; 8: 769-83.
11. Cao F, Wang X, Wang L, Li Z, Che J, Wang L, et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int 2015; 2015: 752930.
12. Dunkley KD, Callaway TR, Chalova VI, McReynolds JL, Hume ME, Dunkley CS, et al. Foodborne Salmonella ecology in the avian gastrointestinal tract. Anaerobe 2009; 15: 26-35.
13. Galarce NE, Bravo JL, Robeson JP, Borie CF. Bacteriophage cocktail reduces Salmonella enterica serovar Enteritidis counts in raw and smoked salmon tissues. Rev Argent Microbiol 2014;46: 333-7.
14. Kutateladze M, Adamia R. Phage therapy experience at the Eliava Institute. Med Mal Infect 2008; 38: 426-30.
15. Harper DR, Enright MC. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl Microbiol 2011; 111: 1-7.
16. Morello E, Saussereau E, Maura D, Huerre M, Touqui L, Debarbieux L: Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: First steps towards treatment and prevention. PLoS One 2011; 6:e16963.
17. Bordon J , Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 2013; 17: 76-83.
18. Kang HW, Kim JW, Jung TS, Woo GJ. wksl3, a new biocontrol agent for Salmonella enterica serovars enteritidis and typhimurium in foods: characterization, application, sequenceanalysis, and oralacute toxicity study. ApplEnviron Microbiol 2013; 79: 1956-68.
19. Gilles B, Armando N, Shafiqul AS, Anne-C P , Firdausi Q , Shamima S, et al. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microb Biotechnol 2014; 7: 165-76.
20. Firoozeh F, Zahraei-Salehi T, Shahcheraghi F, Karimi V, Aslani MM. Characterization of class I integrons among Salmonella enterica serovar Enteritidis isolated from humans and poultry. FEMS Immunol Med Microbiol 2012; 64: 23743.